Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

News & Insights

Lawdragon Names Dave Marriott and Tim Cameron to 2020 List of Legends

September 23, 2020

Cravath partners David R. Marriott and Timothy G. Cameron were named to Lawdragon’s 2020 list of “Legends,” which recognizes the lawyers who have been featured among Lawdragon’s list of the “500 Leading Lawyers in America” for 10 consecutive years. Lawdragon described those on the list as among the “industry’s most elite,” noting Dave’s exemplary work “for decades in the areas of antitrust, securities and intellectual property litigation” and Tim’s client base comprising “many of the world’s leading companies” that trust him “with their most important cases”.

Related Practices & Industries

  • Corporate
  • Mergers and Acquisitions
  • Litigation

People

Photo
Name
David R. Marriott
Title
Litigation
Title
Partner
Email
dmarriott@cravath.com
Phone
+1-212-474-1430
vCard
Download vCard

    Education

    • J.D., 1994, New York University School of Law
    • B.A., 1991, Brigham Young University
      magna cum laude

    Admitted In

    • New York
    Photo
    Name
    Timothy G. Cameron
    Title
    Litigation
    Title
    Partner
    Email
    tcameron@cravath.com
    Phone
    +1-212-474-1120
    vCard
    Download vCard

      Education

      • LL.M., 1998, University of Chicago Law School
      • M.ComLaw, 1997, Auckland University - Faculty of Law
        First Class Honors
      • LL.B., 1994, Auckland University - Faculty of Law
      • B.Com., 1994, Auckland University - Faculty of Law

      Admitted In

      • New York

      Related News & Insights

      Deals & Cases

      July 29, 2019

      Mylan’s $50 Billion Combination with Upjohn, a Division of Pfizer

      On July 29, 2019, Mylan N.V. and Pfizer Inc. announced a definitive agreement to combine Mylan with Upjohn, Pfizer's off-patent branded and generic established medicines business, creating a new global pharmaceutical company. Under the terms of the agreement, which is structured as an all-stock, Reverse Morris Trust transaction, each Mylan share would be converted into one share of the new company. Pfizer shareholders would own 57% of the combined new company, and Mylan shareholders would own 43%. Cravath is representing Mylan in connection with the transaction.

      Deals & Cases

      PG&E Initiates Voluntary Reorganization in Connection with the Resolution of Potential Liabilities Resulting from Northern California Wildfires

      On January 14, 2019, following a comprehensive review, PG&E Corporation (“PG&E” or “the Company”) announced its intent to initiate voluntary reorganization proceedings under chapter 11, through which it intends to address its responsibilities to stakeholders and achieve an orderly, fair and expeditious resolution of potential liabilities resulting from the unprecedented 2017 and 2018 Northern California wildfires. Cravath is representing PG&E as principal advisory counsel; in corporate matters related to its chapter 11 proceedings, including the arrangement of Debtor-in-Possession (“DIP”) financing; and as lead trial counsel in related litigation.

      Cravath Bicentennial

      Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

      Explore

      Cravath, Swaine & Moore LLP Logo
      • CONTACT US
      • OUR STORY
      • ALUMNI PORTAL
      • DISCLAIMERS & NOTICES

      Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.